tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
Holding IBRX?
Track your performance easily

ImmunityBio (IBRX) Financial Statements

1,162 Followers

ImmunityBio Financial Overview

ImmunityBio's market cap is currently ―. The company's EPS TTM is $-0.886; its P/E ratio is -5.50; ImmunityBio is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 6.11M$ 1.05M$ 40.00K$ 139.00K$ 82.00K
Gross Profit$ 6.11M$ 1.05M$ 40.00K$ 139.00K$ 82.00K
EBIT$ -85.75M$ -65.77M$ -67.16M$ -201.33M$ -60.62M
EBITDA$ -73.68M$ -53.66M$ -56.20M$ -196.76M$ -56.04M
Net Income Common Stockholders$ -85.73M$ -134.56M$ -134.11M$ -233.39M$ -95.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 130.37M$ 217.98M$ 170.50M$ 266.46M$ 189.80M
Total Assets$ 364.57M$ 444.32M$ 400.68M$ 504.45M$ 432.42M
Total Debt$ 1.02B$ 998.94M$ 894.78M$ 882.14M$ 688.99M
Net Debt$ 886.20M$ 780.96M$ 724.29M$ 615.68M$ 499.19M
Total Liabilities$ 1.11B$ 1.14B$ 1.09B$ 1.09B$ 843.06M
Stockholders Equity$ -745.15M$ -698.39M$ -692.01M$ -586.99M$ -411.72M
Cash Flow-
Free Cash Flow$ -101.56M$ -101.07M$ -108.24M$ -123.23M$ -93.08M
Operating Cash Flow$ -98.76M$ -100.35M$ -106.98M$ -115.27M$ -87.40M
Investing Cash Flow$ 65.03M$ -51.49M$ -35.62M$ 2.25M$ -15.63M
Financing Cash Flow$ 15.58M$ 148.89M$ 10.22M$ 200.54M$ 237.50M
Currency in USD

ImmunityBio Earnings and Revenue History

ImmunityBio Debt to Assets

ImmunityBio Cash Flow

ImmunityBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis